Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maral Soleymani"'
Autor:
Seyed Esmaeil Ahmadi, Elahe Rahimian, Samira Rahimi, Bahman Zarandi, Mehran Bahraini, Maral Soleymani, Seyed Mehrab Safdari, Ashkan Shabannezhad, Niloofar Jaafari, Majid Safa
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-60 (2024)
Abstract The p53 protein, encoded by the TP53 gene, serves as a critical tumor suppressor, playing a vital role in maintaining genomic stability and regulating cellular responses to stress. Dysregulation of p53 is frequently observed in hematological
Externí odkaz:
https://doaj.org/article/edd454dcab5842c794282c615d36013f
Autor:
Vahideh Takhviji, Kazem Zibara, Asma Maleki, Ebrahim Azizi, Sanaz Hommayoun, Mohammadreza Tabatabaei, Seyed Esmaeil Ahmadi, Maral Soleymani, Omid Kiani Ghalesardi, Mina Farokhian, Afshin Davari, Pouria Paridar, Anahita Kalantari, Abbas Khosravi
Publikováno v:
Thrombosis Journal, Vol 19, Iss 1, Pp 1-9 (2021)
Abstract Background Activated protein C resistance (APCR) due to factor V Leiden (FVL) mutation (R506Q) is a major risk factor in patients with venous thromboembolism (VTE). The present study investigated the clinical manifestations and the risk of v
Externí odkaz:
https://doaj.org/article/208b4d93253640ba914b75da94cc2549
Autor:
Mostafa Paridar, Kazem Zibara, Seyed Esmaeil Ahmadi, Abbas Khosravi, Maral Soleymani, Ebrahim Azizi, Omid Kiani Ghalesardi
Publikováno v:
Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-7 (2021)
Abstract Background Myelodysplastic syndrome (MDS), a heterogeneous group of hematopoietic malignancy, has been shown to present different cytogenetic abnormalities, risk factors, and clinico-hematological features in different populations and geogra
Externí odkaz:
https://doaj.org/article/ff0ca38f5bce415291fc598f6fa03dfd
Autor:
Seyed Esmaeil Ahmadi, Maral Soleymani, Fahimeh Shahriyary, Mohammad Reza Amirzargar, Mahya Ofoghi, Mohammad Davood Fattahi, Majid Safa
Publikováno v:
Cancer Gene Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb1178f0ea2c0db1e8f2d3a1bd9735d4
https://doi.org/10.1038/s41417-023-00597-z
https://doi.org/10.1038/s41417-023-00597-z
Autor:
Mina Farokhian, Pouria Paridar, Anahita Kalantari, Maral Soleymani, Omid Kiani Ghalesardi, Vahideh Takhviji, Afshin Davari, Kazem Zibara, Asma Maleki, Mohammadreza Tabatabaei, Seyed Esmaeil Ahmadi, Ebrahim Azizi, Sanaz Hommayoun, Abbas Khosravi
Publikováno v:
Thrombosis Journal, Vol 19, Iss 1, Pp 1-9 (2021)
Thrombosis Journal
Thrombosis Journal
Background Activated protein C resistance (APCR) due to factor V Leiden (FVL) mutation (R506Q) is a major risk factor in patients with venous thromboembolism (VTE). The present study investigated the clinical manifestations and the risk of venous thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e8aac4136126d74d7717cf8d05bdf6f
https://doaj.org/article/208b4d93253640ba914b75da94cc2549
https://doaj.org/article/208b4d93253640ba914b75da94cc2549
Autor:
Abbas Khosravi, Seyed Esmaeil Ahmadi, Mostafa Paridar, Omid Kiani Ghalesardi, Maral Soleymani, Kazem Zibara, Ebrahim Azizi
Publikováno v:
Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-7 (2021)
Molecular Cytogenetics
Molecular Cytogenetics
Background Myelodysplastic syndrome (MDS), a heterogeneous group of hematopoietic malignancy, has been shown to present different cytogenetic abnormalities, risk factors, and clinico-hematological features in different populations and geographic area
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d142e263b62a93bf6ba7e32f92bcf70f
https://doaj.org/article/ff0ca38f5bce415291fc598f6fa03dfd
https://doaj.org/article/ff0ca38f5bce415291fc598f6fa03dfd
Autor:
Saber Soltani, Ramin Shahbahrami, Abbas Farahani, Iraj Pakzad, Fatemeh Abdi, Mina Mobini Kesheh, Milad Zandi, Sara Akhavan Rezayat, Maral Soleymani, Zainab Shateri, Mohammad Reza Karimi, Pooneh Malekifar, Reza Pakzad, Seyed Esmaeil Ahmadi, Parastoo Hosseini
Publikováno v:
Journal of Clinical Laboratory Analysis
Background To provide information about pathogens’ coinfection prevalence with SARS‐CoV‐2 could be a real help to save patients’ lives. This study aims to evaluate the pathogens’ coinfection prevalence among COVID‐19 patients. Method In o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd53e317911953f0a73e830acfd3a637
https://pubmed.ncbi.nlm.nih.gov/34851526
https://pubmed.ncbi.nlm.nih.gov/34851526